Marsha L. Fox

1.6k total citations
20 papers, 1.3k citations indexed

About

Marsha L. Fox is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Marsha L. Fox has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 10 papers in Internal Medicine and 9 papers in Hematology. Recurrent topics in Marsha L. Fox's work include Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Platelet Disorders and Treatments (9 papers). Marsha L. Fox is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Platelet Disorders and Treatments (9 papers). Marsha L. Fox collaborates with scholars based in United States, Denmark and Canada. Marsha L. Fox's co-authors include Andrew L. Frelinger, Alan D. Michelson, Matthew D. Linden, Marc R. Barnard, Mark I. Furman, Youfu Li, M.R. BARNARD, Lori A. Krueger, M.I. Furman and Robert J. Goldberg and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Marsha L. Fox

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marsha L. Fox United States 14 888 403 320 307 225 20 1.3k
Heather M. Judge United Kingdom 22 887 1.0× 335 0.8× 351 1.1× 326 1.1× 93 0.4× 41 1.3k
Jim Thom Australia 17 401 0.5× 473 1.2× 167 0.5× 211 0.7× 99 0.4× 29 1.0k
Sandra Penz Germany 8 518 0.6× 397 1.0× 236 0.7× 200 0.7× 75 0.3× 11 915
D. Tschoepe Germany 19 710 0.8× 359 0.9× 181 0.6× 315 1.0× 58 0.3× 31 1.4k
J. Zahavi United Kingdom 19 471 0.5× 316 0.8× 296 0.9× 333 1.1× 117 0.5× 37 1.1k
Sourav K. Kundu United States 9 567 0.6× 510 1.3× 246 0.8× 264 0.9× 106 0.5× 15 996
Petter Järemo Sweden 16 345 0.4× 173 0.4× 137 0.4× 182 0.6× 74 0.3× 42 889
M Bory France 13 899 1.0× 232 0.6× 203 0.6× 468 1.5× 42 0.2× 69 1.5k
Maddalena Lettino Italy 16 808 0.9× 313 0.8× 174 0.5× 444 1.4× 37 0.2× 63 1.4k
E Heilmann France 16 594 0.7× 910 2.3× 260 0.8× 258 0.8× 73 0.3× 31 1.4k

Countries citing papers authored by Marsha L. Fox

Since Specialization
Citations

This map shows the geographic impact of Marsha L. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marsha L. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marsha L. Fox more than expected).

Fields of papers citing papers by Marsha L. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marsha L. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marsha L. Fox. The network helps show where Marsha L. Fox may publish in the future.

Co-authorship network of co-authors of Marsha L. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Marsha L. Fox. A scholar is included among the top collaborators of Marsha L. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marsha L. Fox. Marsha L. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frelinger, Andrew L., Marc R. Barnard, Marsha L. Fox, & Alan D. Michelson. (2010). The Platelet Activity After Clopidogrel Termination (PACT) Study. Circulation Cardiovascular Interventions. 3(5). 442–449. 24 indexed citations
2.
Frelinger, Andrew L., Youfu Li, Matthew D. Linden, et al.. (2009). Association of Cyclooxygenase-1-Dependent and -Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization. Circulation. 120(25). 2586–2596. 138 indexed citations
3.
Frelinger, Andrew L., Joseph A. Jakubowski, Yun Li, et al.. (2008). The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities. Journal of Thrombosis and Haemostasis. 6(2). 359–365. 33 indexed citations
4.
Frelinger, Andrew L., Matthew D. Linden, Inge Tarnow, et al.. (2008). Aspirin ‘resistance’: role of pre‐existent platelet reactivity and correlation between tests. Journal of Thrombosis and Haemostasis. 6(12). 2035–2044. 69 indexed citations
5.
Frelinger, Andrew L., Joseph A. Jakubowski, M.R. BARNARD, et al.. (2008). The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities. Journal of Thrombosis and Haemostasis. 6(2). 359–365. 2 indexed citations
6.
Frelinger, Andrew L., J.A. Jakubowski, M.R. BARNARD, et al.. (2007). The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. Journal of Thrombosis and Haemostasis. 98(1). 192–200. 5 indexed citations
7.
Linden, Matthew D., M.I. Furman, Andrew L. Frelinger, et al.. (2007). Indices of platelet activation and the stability of coronary artery disease. Journal of Thrombosis and Haemostasis. 5(4). 761–765. 94 indexed citations
8.
Tarnow, Inge, Alan D. Michelson, Andrew L. Frelinger, et al.. (2007). Cystic fibrosis heterozygotes do not have increased platelet activation. Thrombosis Research. 121(2). 159–162. 3 indexed citations
9.
Jakubowski, Joseph A., Marc R. Barnard, Marsha L. Fox, et al.. (2007). The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. Thrombosis and Haemostasis. 98(7). 192–200. 38 indexed citations
10.
Frelinger, Andrew L., Mark I. Furman, Matthew D. Linden, et al.. (2006). Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway. Circulation. 113(25). 2888–2896. 227 indexed citations
11.
Michelson, Alan D., Matthew D. Linden, M.I. Furman, et al.. (2006). Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’. Journal of Thrombosis and Haemostasis. 5(1). 75–81. 70 indexed citations
12.
Furman, M.I., Lori A. Krueger, Matthew D. Linden, et al.. (2005). GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Journal of Thrombosis and Haemostasis. 3(2). 312–320. 39 indexed citations
13.
BARNARD, M.R., Matthew D. Linden, Andrew L. Frelinger, et al.. (2005). Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity. Journal of Thrombosis and Haemostasis. 3(11). 2563–2570. 66 indexed citations
14.
Frelinger, Andrew L., Matthew D. Linden, Mark I. Furman, et al.. (2004). Patients with Coronary Artery Disease Have an Increased Incidence of Aspirin Resistance: Association of PFA-100 Closure Time with Clinical Findings.. Blood. 104(11). 1859–1859. 3 indexed citations
15.
Furman, Mark I., Dean J. Kereiakes, Lori A. Krueger, et al.. (2003). Quantification of abciximab-induced platelet inhibition is assay dependent: A comparative study in patients undergoing percutaneous coronary intervention. American Heart Journal. 145(2). M1–M6. 6 indexed citations
16.
17.
Furman, Mark I., Marc R. Barnard, Lori A. Krueger, et al.. (2001). Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. Journal of the American College of Cardiology. 38(4). 1002–1006. 331 indexed citations
18.
Javorski, Joseph J., Dolly D. Hansen, Peter C. Laussen, et al.. (1995). Paediatric cardiac catheterization: innovations. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 42(4). 310–329. 13 indexed citations
19.
Laussen, Peter C., Dolly D. Hansen, Stanton B. Perry, et al.. (1995). Transcatheter Closure of Ventricular Septal Defects. Anesthesia & Analgesia. 80(6). 1076–1082. 33 indexed citations
20.
Hickey, Paul R., David Wessel, Marsha L. Fox, et al.. (1992). Transcatheter Closure of Atrial Septal Defects. Anesthesia & Analgesia. 74(1). 44???50–44???50. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather M. Judge Breakdown of academic impact, for papers by Jim Thom Breakdown of academic impact, for papers by Sandra Penz Breakdown of academic impact, for papers by D. Tschoepe Breakdown of academic impact, for papers by J. Zahavi Breakdown of academic impact, for papers by Sourav K. Kundu Breakdown of academic impact, for papers by Petter Järemo Breakdown of academic impact, for papers by M Bory Breakdown of academic impact, for papers by Maddalena Lettino Breakdown of academic impact, for papers by E Heilmann
Rankless by CCL
2026